Scopa James Paul
SEC-identified person · CIK 1356950 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aligos Therapeutics, Inc. ALGS | Director | filed 2021 - 2026 |
| Avalanche Biotechnologies, Inc. [AAVL] | Director | filed 2019 - 2025 |
| Dice Therapeutics, Inc. DICE | Director | filed 2021 - 2023 |
| Histogen Inc. HSTO | Director | filed 2013 - 2018 |
| Radius Health, Inc. RDUS | Officer | filed 2011 - 2016 |
| Syndax Pharmaceuticals Inc SNDX | Officer | filed 2016 - 2016 |
| Trivascular Technologies, Inc. TRIV | Director | filed 2014 - 2016 |
| Cerecor Inc. CERC | Officer | filed 2015 - 2015 |
| Chiasma, INC CHMA | Officer | filed 2015 - 2015 |
| Aratana Therapeutics, INC. PETX | Officer | filed 2013 - 2014 |
| Epizyme, Inc. EPZM | Officer | filed 2013 - 2014 |
| Pacira Pharmaceuticals, Inc. PCRX | Officer | filed 2011 - 2013 |
| Verastem, Inc. VSTM | Officer | filed 2012 - 2012 |
| Peplin INC PLIN | Director | filed 2009 - 2009 |
| Memory Pharmaceuticals Corp MEMY | Officer | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.